---
$id: https://graph.org.ai/products/commodity/51142522
$type: Product
source: UNSPSC
code: "51142522"
title: "Dihydroergocryptine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dihydroergocryptine

**UNSPSC Code**: 51142522
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinson drug with the molecular formula C32H43N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67V3FSL2GL, chemically known as ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, but generally known as Dihydroergocryptine, which bears US NIH Compound Identifier 114948. European Medicines Agency schedules Dihydroergocryptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13588MIG. World Health Organization schedules amantadine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIHYDROERGOCRYPTINE remains the US FDA Preferred Term for this commodity. SMILES: CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.

